ATE383856T1 - (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien - Google Patents

(4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien

Info

Publication number: ATE383856T1
Authority: AT; Austria
Prior art keywords: sub; carbaldehydoxime; indole; hydroxyphenyl; derivatives
Prior art date: 2003-08-12

Application number

AT04780574T

Other languages

English (en)

Inventor

Richard Eric Mewshaw

Stephen Bowen

Eric Manas

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-12

Filing date

2004-08-10

Publication date

2008-02-15

2004-08-10 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-02-15 Application granted granted Critical

2008-02-15 Publication of ATE383856T1 publication Critical patent/ATE383856T1/de

Links

PUZSIQXETQCQII-UHFFFAOYSA-N 4-[3-(hydroxyiminomethyl)indol-1-yl]phenol Chemical class C12=CC=CC=C2C(C=NO)=CN1C1=CC=C(O)C=C1 PUZSIQXETQCQII-UHFFFAOYSA-N 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
229940011871 estrogen Drugs 0.000 title 1
239000000262 estrogen Substances 0.000 title 1
239000002834 estrogen receptor modulator Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Oncology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Pregnancy & Childbirth (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Toxicology (AREA)

AT04780574T 2003-08-12 2004-08-10 (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien ATE383856T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US49436503P	2003-08-12	2003-08-12
US10/914,747 US7250440B2 (en)	2003-08-12	2004-08-09	(Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents

Publications (1)

Publication Number	Publication Date
ATE383856T1 true ATE383856T1 (de)	2008-02-15

Family

ID=34221360

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04780574T ATE383856T1 (de)	2003-08-12	2004-08-10	(4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien

Country Status (13)

Country	Link
US (2)	US7250440B2 (de)
EP (1)	EP1653947B1 (de)
JP (1)	JP2007502277A (de)
AT (1)	ATE383856T1 (de)
AU (1)	AU2004266603A1 (de)
BR (1)	BRPI0413523A (de)
CA (1)	CA2535341A1 (de)
DE (1)	DE602004011358T2 (de)
DK (1)	DK1653947T3 (de)
ES (1)	ES2298823T3 (de)
MX (1)	MXPA06001592A (de)
PL (1)	PL1653947T3 (de)
WO (1)	WO2005018636A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2564694T3 (es)	2003-09-12	2016-03-28	Vessix Vascular, Inc.	Sistema de remodelación y / o ablación excéntrica seleccionable de material ateroesclerótico
CN101052641A (zh)	2004-09-07	2007-10-10	惠氏公司	6H－[1]苯并吡喃并[4,3－b]喹啉及其作为雌激素药物的用途
US8396548B2 (en)	2008-11-14	2013-03-12	Vessix Vascular, Inc.	Selective drug delivery in a lumen
US8920414B2 (en)	2004-09-10	2014-12-30	Vessix Vascular, Inc.	Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
US9713730B2 (en)	2004-09-10	2017-07-25	Boston Scientific Scimed, Inc.	Apparatus and method for treatment of in-stent restenosis
US20070185184A1 (en) *	2005-09-16	2007-08-09	Serenex, Inc.	Carbazole derivatives
US8019435B2 (en)	2006-05-02	2011-09-13	Boston Scientific Scimed, Inc.	Control of arterial smooth muscle tone
EP2076194B1 (de)	2006-10-18	2013-04-24	Vessix Vascular, Inc.	System zur herbeiführung gewünschter temperatureffekte in körpergewebe
EP2076198A4 (de)	2006-10-18	2009-12-09	Minnow Medical Inc	Herbeiführung gewünschter temperatureffekte auf körpergewebe
US9623021B2 (en) *	2007-01-22	2017-04-18	Gtx, Inc.	Nuclear receptor binding agents
US9604931B2 (en)	2007-01-22	2017-03-28	Gtx, Inc.	Nuclear receptor binding agents
EA026578B1 (ru)	2007-01-22	2017-04-28	ДЖиТиЭкс, ИНК.	Вещества, связывающие ядерные рецепторы
GB0803017D0 (en) *	2008-02-19	2008-03-26	Glaxo Group Ltd	Compounds
HUE025471T2 (hu)	2008-04-16	2016-03-29	Karobio Ab	Új ösztrogén receptor ligandumok
GB0817221D0 (en) *	2008-09-19	2008-10-29	Karobio Ab	Novel estrogen receptor ligands
JP5307900B2 (ja)	2008-11-17	2013-10-02	べシックス・バスキュラー・インコーポレイテッド	組織トポグラフィの知識によらないエネルギーの選択的な蓄積
TW201124406A (en) *	2009-10-07	2011-07-16	Karobio Ab	Novel estrogen receptor ligands
GB0917571D0 (en)	2009-10-07	2009-11-25	Karobio Ab	Novel estrogen receptor ligands
CN103068330B (zh)	2010-04-09	2016-06-29	Vessix血管股份有限公司	用于治疗组织的功率发生和控制装置
US9192790B2 (en)	2010-04-14	2015-11-24	Boston Scientific Scimed, Inc.	Focused ultrasonic renal denervation
US8473067B2 (en)	2010-06-11	2013-06-25	Boston Scientific Scimed, Inc.	Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9084609B2 (en)	2010-07-30	2015-07-21	Boston Scientific Scime, Inc.	Spiral balloon catheter for renal nerve ablation
US9408661B2 (en)	2010-07-30	2016-08-09	Patrick A. Haverkost	RF electrodes on multiple flexible wires for renal nerve ablation
US9463062B2 (en)	2010-07-30	2016-10-11	Boston Scientific Scimed, Inc.	Cooled conductive balloon RF catheter for renal nerve ablation
US9358365B2 (en)	2010-07-30	2016-06-07	Boston Scientific Scimed, Inc.	Precision electrode movement control for renal nerve ablation
US9155589B2 (en)	2010-07-30	2015-10-13	Boston Scientific Scimed, Inc.	Sequential activation RF electrode set for renal nerve ablation
US8974451B2 (en)	2010-10-25	2015-03-10	Boston Scientific Scimed, Inc.	Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en)	2010-10-27	2015-12-29	Boston Scientific Scimed, Inc.	RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en)	2010-11-15	2015-05-12	Boston Scientific Scimed, Inc.	Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en)	2010-11-16	2015-07-28	Boston Scientific Scimed, Inc.	Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en)	2010-11-16	2017-06-06	Boston Scientific Scimed, Inc.	Minimally invasive access for renal nerve ablation
US9326751B2 (en)	2010-11-17	2016-05-03	Boston Scientific Scimed, Inc.	Catheter guidance of external energy for renal denervation
US9060761B2 (en)	2010-11-18	2015-06-23	Boston Scientific Scime, Inc.	Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en)	2010-11-22	2015-05-05	Boston Scientific Scimed, Inc.	Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en)	2010-11-22	2015-11-24	Boston Scientific Scimed, Inc.	Renal denervation catheter with cooled RF electrode
US20120157993A1 (en)	2010-12-15	2012-06-21	Jenson Mark L	Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US9220561B2 (en)	2011-01-19	2015-12-29	Boston Scientific Scimed, Inc.	Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
GB201105979D0 (en)	2011-04-07	2011-05-18	Karobio Ab	Novel estrogen receptor ligands
AU2012283908B2 (en)	2011-07-20	2017-02-16	Boston Scientific Scimed, Inc.	Percutaneous devices and methods to visualize, target and ablate nerves
CN103813829B (zh)	2011-07-22	2016-05-18	波士顿科学西美德公司	具有可定位于螺旋引导件中的神经调制元件的神经调制系统
GB201113538D0 (en)	2011-08-04	2011-09-21	Karobio Ab	Novel estrogen receptor ligands
EP2765942B1 (de)	2011-10-10	2016-02-24	Boston Scientific Scimed, Inc.	Medizinische vorrichtungen mit ablationselektroden
WO2013055815A1 (en)	2011-10-11	2013-04-18	Boston Scientific Scimed, Inc.	Off -wall electrode device for nerve modulation
US9420955B2 (en)	2011-10-11	2016-08-23	Boston Scientific Scimed, Inc.	Intravascular temperature monitoring system and method
US9364284B2 (en)	2011-10-12	2016-06-14	Boston Scientific Scimed, Inc.	Method of making an off-wall spacer cage
US9162046B2 (en)	2011-10-18	2015-10-20	Boston Scientific Scimed, Inc.	Deflectable medical devices
US9079000B2 (en)	2011-10-18	2015-07-14	Boston Scientific Scimed, Inc.	Integrated crossing balloon catheter
CN108095821B (zh)	2011-11-08	2021-05-25	波士顿科学西美德公司	孔部肾神经消融
US9119600B2 (en)	2011-11-15	2015-09-01	Boston Scientific Scimed, Inc.	Device and methods for renal nerve modulation monitoring
US9119632B2 (en)	2011-11-21	2015-09-01	Boston Scientific Scimed, Inc.	Deflectable renal nerve ablation catheter
US9265969B2 (en)	2011-12-21	2016-02-23	Cardiac Pacemakers, Inc.	Methods for modulating cell function
JP6158830B2 (ja)	2011-12-23	2017-07-05	べシックス・バスキュラー・インコーポレイテッド	身体通路の組織又は身体通路に隣接する組織をリモデリングするためのシステム、方法及び装置
WO2013101452A1 (en)	2011-12-28	2013-07-04	Boston Scientific Scimed, Inc.	Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en)	2011-12-29	2015-06-09	Boston Scientific Scimed, Inc.	Off-wall electrode device and methods for nerve modulation
WO2013169927A1 (en)	2012-05-08	2013-11-14	Boston Scientific Scimed, Inc.	Renal nerve modulation devices
WO2014032016A1 (en)	2012-08-24	2014-02-27	Boston Scientific Scimed, Inc.	Intravascular catheter with a balloon comprising separate microporous regions
WO2014043687A2 (en)	2012-09-17	2014-03-20	Boston Scientific Scimed, Inc.	Self-positioning electrode system and method for renal nerve modulation
WO2014047411A1 (en)	2012-09-21	2014-03-27	Boston Scientific Scimed, Inc.	System for nerve modulation and innocuous thermal gradient nerve block
WO2014047454A2 (en)	2012-09-21	2014-03-27	Boston Scientific Scimed, Inc.	Self-cooling ultrasound ablation catheter
JP6074051B2 (ja)	2012-10-10	2017-02-01	ボストンサイエンティフィックサイムド，インコーポレイテッドＢｏｓｔｏｎＳｃｉｅｎｔｉｆｉｃＳｃｉｍｅｄ，Ｉｎｃ．	血管内神経変調システム及び医療用デバイス
US9956033B2 (en)	2013-03-11	2018-05-01	Boston Scientific Scimed, Inc.	Medical devices for modulating nerves
US9693821B2 (en)	2013-03-11	2017-07-04	Boston Scientific Scimed, Inc.	Medical devices for modulating nerves
US9808311B2 (en)	2013-03-13	2017-11-07	Boston Scientific Scimed, Inc.	Deflectable medical devices
US10265122B2 (en)	2013-03-15	2019-04-23	Boston Scientific Scimed, Inc.	Nerve ablation devices and related methods of use
EP2967725B1 (de)	2013-03-15	2019-12-11	Boston Scientific Scimed, Inc.	Steuervorrichtung zur leckstromdetektion zwischen elektrodenpads und anlage mit einer solchen steuervorrichtung
JP6220044B2 (ja)	2013-03-15	2017-10-25	ボストンサイエンティフィックサイムド，インコーポレイテッドＢｏｓｔｏｎＳｃｉｅｎｔｉｆｉｃＳｃｉｍｅｄ，Ｉｎｃ．	腎神経アブレーションのための医療用デバイス
WO2014205399A1 (en)	2013-06-21	2014-12-24	Boston Scientific Scimed, Inc.	Medical devices for renal nerve ablation having rotatable shafts
EP3010437A1 (de)	2013-06-21	2016-04-27	Boston Scientific Scimed, Inc.	Nierendenervierungsballonkatheter mit lauf entlang eines elektrodenträgers
US9707036B2 (en)	2013-06-25	2017-07-18	Boston Scientific Scimed, Inc.	Devices and methods for nerve modulation using localized indifferent electrodes
JP6204579B2 (ja)	2013-07-01	2017-09-27	ボストンサイエンティフィックサイムド，インコーポレイテッドＢｏｓｔｏｎＳｃｉｅｎｔｉｆｉｃＳｃｉｍｅｄ，Ｉｎｃ．	腎神経アブレーション用医療器具
US10413357B2 (en)	2013-07-11	2019-09-17	Boston Scientific Scimed, Inc.	Medical device with stretchable electrode assemblies
WO2015006480A1 (en)	2013-07-11	2015-01-15	Boston Scientific Scimed, Inc.	Devices and methods for nerve modulation
US9925001B2 (en)	2013-07-19	2018-03-27	Boston Scientific Scimed, Inc.	Spiral bipolar electrode renal denervation balloon
US10342609B2 (en)	2013-07-22	2019-07-09	Boston Scientific Scimed, Inc.	Medical devices for renal nerve ablation
CN105392435B (zh)	2013-07-22	2018-11-09	波士顿科学国际有限公司	具有扭绞球囊的肾神经消融导管
US10722300B2 (en)	2013-08-22	2020-07-28	Boston Scientific Scimed, Inc.	Flexible circuit having improved adhesion to a renal nerve modulation balloon
WO2015035047A1 (en)	2013-09-04	2015-03-12	Boston Scientific Scimed, Inc.	Radio frequency (rf) balloon catheter having flushing and cooling capability
WO2015038947A1 (en)	2013-09-13	2015-03-19	Boston Scientific Scimed, Inc.	Ablation balloon with vapor deposited cover layer
EP3057488B1 (de)	2013-10-14	2018-05-16	Boston Scientific Scimed, Inc.	Elektrodenarraykatheter für hochauflösende kardiale kartierung
US11246654B2 (en)	2013-10-14	2022-02-15	Boston Scientific Scimed, Inc.	Flexible renal nerve ablation devices and related methods of use and manufacture
US9770606B2 (en)	2013-10-15	2017-09-26	Boston Scientific Scimed, Inc.	Ultrasound ablation catheter with cooling infusion and centering basket
US9962223B2 (en)	2013-10-15	2018-05-08	Boston Scientific Scimed, Inc.	Medical device balloon
US10945786B2 (en)	2013-10-18	2021-03-16	Boston Scientific Scimed, Inc.	Balloon catheters with flexible conducting wires and related methods of use and manufacture
US10271898B2 (en)	2013-10-25	2019-04-30	Boston Scientific Scimed, Inc.	Embedded thermocouple in denervation flex circuit
EP3091922B1 (de)	2014-01-06	2018-10-17	Boston Scientific Scimed, Inc.	Reissfeste flexible schaltungsanordnung
US11000679B2 (en)	2014-02-04	2021-05-11	Boston Scientific Scimed, Inc.	Balloon protection and rewrapping devices and related methods of use
EP3424453B1 (de)	2014-02-04	2026-04-01	Boston Scientific Scimed, Inc.	Alternative platzierung von thermischen sensoren auf bipolarer elektrode
GB202011812D0 (en) *	2020-07-29	2020-09-09	Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid	Compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2707268A1 (de) *	1977-02-19	1978-08-31	Hoechst Ag	Indol-3-carbaldehyd-oxime und verfahren zu ihrer herstellung
US4418068A (en) *	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
US5998402A (en) *	1996-04-19	1999-12-07	American Home Products Corporation	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
DE19615370A1 (de)	1996-04-19	1997-10-23	Voith Sulzer Papiermasch Gmbh	Verfahren und Vorrichtung zum Durchtrennen einer laufenden Warenbahn
PT802183E (pt) *	1996-04-19	2002-03-28	American Home Prod	Agentes estrogenicos
US6060488A (en) *	1998-09-22	2000-05-09	Eli Lilly And Company	Benzothiophenes for treating estrogen deficiency
JP2002538141A (ja) *	1999-03-04	2002-11-12	ワイス	エストロゲン剤としてのｎ−置換ベンゾイルインドール

2004
- 2004-08-09 US US10/914,747 patent/US7250440B2/en not_active Expired - Fee Related
- 2004-08-10 MX MXPA06001592A patent/MXPA06001592A/es active IP Right Grant
- 2004-08-10 WO PCT/US2004/025764 patent/WO2005018636A1/en not_active Ceased
- 2004-08-10 AT AT04780574T patent/ATE383856T1/de not_active IP Right Cessation
- 2004-08-10 ES ES04780574T patent/ES2298823T3/es not_active Expired - Lifetime
- 2004-08-10 PL PL04780574T patent/PL1653947T3/pl unknown
- 2004-08-10 JP JP2006523281A patent/JP2007502277A/ja active Pending
- 2004-08-10 BR BRPI0413523-7A patent/BRPI0413523A/pt not_active IP Right Cessation
- 2004-08-10 AU AU2004266603A patent/AU2004266603A1/en not_active Abandoned
- 2004-08-10 EP EP04780574A patent/EP1653947B1/de not_active Expired - Lifetime
- 2004-08-10 DK DK04780574T patent/DK1653947T3/da active
- 2004-08-10 DE DE602004011358T patent/DE602004011358T2/de not_active Expired - Fee Related
- 2004-08-10 CA CA002535341A patent/CA2535341A1/en not_active Abandoned
2007
- 2007-06-20 US US11/765,548 patent/US20070249703A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2007502277A (ja)	2007-02-08
DE602004011358D1 (de)	2008-03-06
BRPI0413523A (pt)	2006-10-10
EP1653947B1 (de)	2008-01-16
PL1653947T3 (pl)	2008-05-30
AU2004266603A1 (en)	2005-03-03
US20050059723A1 (en)	2005-03-17
EP1653947A1 (de)	2006-05-10
CA2535341A1 (en)	2005-03-03
ES2298823T3 (es)	2008-05-16
MXPA06001592A (es)	2006-05-19
US7250440B2 (en)	2007-07-31
DE602004011358T2 (de)	2009-01-15
DK1653947T3 (da)	2008-04-28
US20070249703A1 (en)	2007-10-25
WO2005018636A1 (en)	2005-03-03

Legal Events

Date	Code	Title	Description
2008-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE383856T1 (de)	2008-02-15	(4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien
DK1620392T3 (da)	2007-10-15	Hydroxy-biphenyl-carbaldehydoxim-derivater og deres anvendelse som östrogene midler
DK1633699T3 (da)	2007-03-26	Aryl-carbaldehydroximderivater og deres anvendelse som östrogene midler
TW200505902A (en)	2005-02-16	Cannabinoid receptor ligands
UA83620C2 (ru)	2008-08-11	Замещенные бензоксазолы и их аналоги как эстрогенные агенты
BR0215042A (pt)	2006-06-06	fenil-naftalenos substituìdos como agentes estrogênicos
DK1446394T3 (da)	2007-03-12	Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer
NO20055135L (no)	2005-12-14	Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20043996L (no)	2005-04-25	Fremgangsmate for frembringelse av API'er
NO20055516L (no)	2005-11-22	Kannabinoidreceptorligander og anvendelser derav
NO20052995D0 (no)	2005-06-17	1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
MXPA04005784A (es)	2004-09-13	2-fenilbenzofuranos sustituidos como agentes estrogenitos.
DK1643984T3 (da)	2011-10-24	Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
ATE374190T1 (de)	2007-10-15	Tetrahydrochinazolinderivate als cfr-antagonisten
DK1440059T3 (da)	2008-07-14	3-azabicyclo(3.1.0)hexanderivater som opioidreceptorantagonister
DE60313350D1 (de)	2007-05-31	Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
ATE318810T1 (de)	2006-03-15	3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
TW200612925A (en)	2006-05-01	Prodrug substituted benzoxazoles as estrogenic agents
ATE407133T1 (de)	2008-09-15	2-imidazo-benzothiazole als adenosin-rezeptor liganden
ATE465151T1 (de)	2010-05-15	4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
CY1110139T1 (el)	2015-01-14	Γλυκοπεπτιδικα αντιβιοτικα